Writing
Waypoint Bio: Immune Engineering
Announcing Waypoint Bio's $20M Series A and their mission to bring precision engineering to therapeutics.
Introducing Amplify Bio's new advisors
Welcoming Hani Goodarzi, Michael Fischbach, Steve Holtzman, and Patrick Loerch to the Amplify Bio team.
Infinitopes: Preventing Cancer Recurrence
Roughly 70-90% of cancer mortality can be attributed to metastasis. Infinitopes is one of our best shots at solving it.
Cancer's 95% problem
What if you could turn finding cancer drugs into a data problem?
